NASDAQ · LGND
Ligand Pharmaceuticals Incorporated
$319.98+$2.65 (+0.84%)
Ligand Pharmaceuticals Incorporated’s quoted price sits in the upper half of its reported 52-week range, 2.04% below the high.
Loading market information…
OTC · OMHE · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
OMNI Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Omni Health, Inc., through its subsidiary, Malecon Pharmacy, Inc., operates a pharmacy in Hialeah, Florida. It provides health, wellness, and pharmacy services; and manufactures, sells, and distributes anti-aging cream. The company is headquartered in Hialeah, Florida. Omni Health, Inc. is a subsidiary of LX Retail Group, Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:59 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$319.98+$2.65 (+0.84%)
Ligand Pharmaceuticals Incorporated’s quoted price sits in the upper half of its reported 52-week range, 2.04% below the high.
$1.28$0.00 (0.0%)
Sonendo, Inc.’s quoted price sits in the upper half of its reported 52-week range, 32.63% below the high.
$0.01$0.00 (0.0%)
SETO Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.07% below the high.
$0.00$0.00 (0.0%)
Current Energy and Renewables Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Black Bird Biotech, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00+$0.00 (+550.0%)
Novo Integrated Sciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 87.42% below the high.
$0.01$0.00 (0.0%)
Panbela Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.56% below the high.
$0.00$0.00 (0.0%)
The Amacore Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
